NR

Narsimha Reddy Nathi

Director Director DIN 02264640
DIN 02264640 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2008
Shareholding value •••• Premium profile

About Narsimha Reddy Nathi

Data last updated:

Narsimha Reddy Nathi was a Director at Leo Star Healthcare Private Limited (2008–2012) and Director at Winmark Life Sciences Private Limited (2015–2016). The companies operate in Pharma and Healthcare.

DIN 02264640
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Leo Star Healthcare Private Limited U85110TG2008PTC060650
Director20 Aug 20082008₹16.04 Cr (FY 2024)Active
Director15 Apr 20152015₹64 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Leo Star Healthcare Private Limited
Winmark Life Sciences Private Limited
Premium access

Shareholding and investment profile for Narsimha Reddy Nathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narsimha Reddy Nathi

Narsimha Reddy Nathi was first appointed on 20 Aug 2008 as Director at Leo Star Healthcare Private Limited. The most recent appointment on record is 15 Apr 2015 at Winmark Life Sciences Private Limited.

Narsimha Reddy Nathi held 2 earlier board appointments: Leo Star Healthcare Private Limited (Director, 20 Aug 2008 to 09 Mar 2012); Winmark Life Sciences Private Limited (Director, 15 Apr 2015 to 01 Jul 2016).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available